Charles Balabaud Selected Research

Liver Cell Adenoma (Hepatocellular Adenoma)

1/2021	Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
1/2021	Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches.
1/2020	Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas.
1/2020	Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
10/2019	Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.
1/2019	A difficult case of β-catenin-mutated hepatocellular adenoma: a lesson for diagnosis.
1/2019	Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
1/2019	OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
12/2017	Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
12/2017	Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles Balabaud Research Topics

Disease

35	Neoplasms (Cancer) 01/2021 - 04/2003
34	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2021 - 11/2003
21	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2002
12	Focal Nodular Hyperplasia 01/2019 - 03/2003
10	Adenoma (Adenomas) 01/2020 - 04/2003
10	Fibrosis (Cirrhosis) 12/2014 - 04/2003
8	Hemorrhage 11/2021 - 08/2009
6	Carcinogenesis 05/2012 - 03/2005
4	Inflammation (Inflammations) 12/2011 - 01/2006
3	Carcinoma (Carcinomatosis) 01/2020 - 03/2006
3	Glycogen Storage Disease (Glycogenosis) 04/2014 - 01/2008
2	Necrosis 01/2018 - 01/2013
2	Cholestasis 12/2017 - 01/2013
2	Liver Neoplasms (Liver Cancer) 11/2016 - 12/2012
2	Type 3 Maturity-Onset Diabetes of the Young 01/2013 - 11/2003
1	Hemangioma (Angioma) 12/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2013
1	Vascular Diseases (Vascular Disease) 01/2013
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2013
1	Granuloma 09/2012
1	Overweight 09/2012
1	Obesity 09/2012
1	Cholangiocarcinoma 06/2010
1	Colonic Neoplasms (Colon Cancer) 06/2010
1	Epithelioid Hemangioendothelioma 08/2008
1	Infections 06/2008

Drug/Important Bio-Agent (IBA)

17	CateninsIBA 11/2021 - 12/2010
14	beta CateninIBA 01/2021 - 03/2006
10	Oral ContraceptivesIBA 01/2019 - 03/2003
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
6	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2021 - 03/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2009
5	C-Reactive ProteinIBA 10/2019 - 01/2010
5	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2015 - 03/2005
4	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 09/2008 - 11/2003
3	Fatty Acid-Binding ProteinsIBA 01/2020 - 03/2009
3	Hepatocyte Nuclear FactorsIBA 01/2020 - 04/2015
3	ParaffinIBA 12/2017 - 04/2017
3	Glutamine (L-Glutamine)FDA Link 12/2016 - 02/2008
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2016 - 03/2009
3	Hormones (Hormone)IBA 04/2014 - 01/2008
3	Adenosine Triphosphatases (ATPase)IBA 12/2012 - 10/2007
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 10/2019 - 12/2017
2	Formaldehyde (Formol)FDA Link 12/2017 - 12/2017
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2016 - 06/2008
2	Messenger RNA (mRNA)IBA 11/2009 - 10/2007
2	Transcription Factors (Transcription Factor)IBA 01/2008 - 05/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 12/2006
2	Biological ProductsIBA 02/2006 - 12/2003
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Janus KinasesIBA 01/2020
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2019
1	Reticulin (Reticular Fiber)IBA 12/2017
1	Coloring Agents (Dyes)IBA 12/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2017
1	Hematoxylin (Haematoxylon)IBA 12/2017
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 11/2016
1	CollagenIBA 11/2016
1	Lysine (L-Lysine)FDA Link 10/2015
1	CyclinsIBA 10/2015
1	Cyclin A2IBA 10/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015
1	MethyltransferasesIBA 10/2015
1	Aflatoxin B1 (Aflatoxin B)IBA 05/2015
1	Keratin-7 (Cytokeratin 7)IBA 08/2014
1	Colloids (Colloid)IBA 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 12/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2012
1	ChromatinIBA 05/2012
1	Mitogen-Activated Protein KinasesIBA 05/2012
1	Cyclic AMP (AMP, Cyclic)IBA 01/2012
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2012
1	InterferonsIBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2011
1	ErbB Receptors (EGF Receptor)IBA 12/2011
1	Connective Tissue Growth FactorIBA 12/2011
1	Cytokine Receptor gp130IBA 07/2011
1	PeriostinIBA 06/2010
1	Indicators and Reagents (Reagents)IBA 06/2010
1	Protein Isoforms (Isoforms)IBA 11/2009
1	RNA Precursors (Precursor, mRNA)IBA 11/2009
1	AmphiregulinIBA 11/2009
1	LigandsIBA 01/2009
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2009
1	MicroRNAs (MicroRNA)IBA 06/2008
1	Small Interfering RNA (siRNA)IBA 10/2007
1	DNA HelicasesIBA 10/2007
1	CeramidesIBA 10/2007
1	AgarIBA 10/2007
1	Hepatocyte Nuclear Factor 1IBA 05/2007
1	CarbohydratesIBA 05/2007
1	LipidsIBA 05/2007

Therapy/Procedure

3	Hepatectomy 04/2017 - 11/2005
3	Therapeutics 01/2007 - 01/2002
2	Ligation 01/2007 - 04/2003
1	Critical Care (Surgical Intensive Care) 11/2021
1	Lasers (Laser) 12/2017
1	Drug Therapy (Chemotherapy) 01/2013
1	Laparotomy 09/2012
1	Liver Transplantation 08/2008